Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)
Top Cited Papers
Open Access
- 23 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 268 (9), 3059-3071
- https://doi.org/10.1007/s00415-021-10406-y
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in Wuhan, China in December 2019. It is evident that the COVID-19 pandemic has become a challenging world issue. Although most COVID-19 patients primarily develop respiratory symptoms, an increasing number of neurological symptoms and manifestations associated with COVID-19 have been observed. In this narrative review, we elaborate on proposed neurotropic mechanisms and various neurological symptoms, manifestations, and complications of COVID-19 reported in the present literature. For this purpose, a review of all current published literature (studies, case reports, case series, reviews, editorials, and other articles) was conducted and neurological sequelae of COVID-19 were summarized. Essential and common neurological symptoms including gustatory and olfactory dysfunctions, myalgia, headache, altered mental status, confusion, delirium, and dizziness are presented separately in sections. Moreover, neurological manifestations and complications that are of great concern such as stroke, cerebral (sinus) venous thrombosis, seizures, meningoencephalitis, Guillain–Barré syndrome, Miller Fisher syndrome, acute myelitis, and posterior reversible encephalopathy syndrome (PRES) are also addressed systematically. Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further clarify and assess the link between neurological complications and the clinical outcome of patients with COVID-19. To limit long-term consequences, it is crucial that healthcare professionals can early detect possible neurological symptoms and are well versed in the increasingly common neurological manifestations and complications of COVID-19.Keywords
Funding Information
- Projekt DEAL
This publication has 154 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?Viruses, 2019
- Miller Fisher syndrome developing as a parainfectious manifestation of dengue fever: a case report and review of the literatureJournal of Medical Case Reports, 2019
- Varied antibody reactivities and clinical relevance in anti-GQ1b antibody–related diseasesNeurology Neuroimmunology & Neuroinflammation, 2018
- Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of KoreaInfection & Chemotherapy, 2016
- Viral diseases of the central nervous systemCurrent Opinion in Virology, 2015
- Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in HumansPublished by Springer Science and Business Media LLC ,2014
- Diagnosis and Management of Cerebral Venous ThrombosisStroke, 2011
- Pigmented villonodular synovitis with bone involvementArchives of orthopaedic and trauma surgery, 1981